The Enterprise Value as of November 2024 (TTM) for Novartis AG (NVSEF) is 222.02B

According to Novartis AG’s latest financial reports and current stock price. The company's current Enterprise Value is 222.02B. This represents a change of -1.98% compared to the average of 226.51B of the last 4 quarters.

Novartis AG (NVSEF) Historical Enterprise Value (quarterly & annually)

How has NVSEF Enterprise Value performed in the past?

The mean historical Enterprise Value of Novartis AG over the last ten years is 216.89B. The current 222.02B Enterprise Value has changed 10.14% with respect to the historical average. Over the past ten years (40 quarters), NVSEF's Enterprise Value was at its highest in in the June 2015 quarter at 255.75B. The Enterprise Value was at its lowest in in the September 2022 quarter at 175.45B.

Novartis AG (NVSEF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Novartis AG Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Novartis AG (NVSEF) Average Enterprise Value

How has NVSEF Enterprise Value performed in the past?

The current Enterprise Value of Novartis AG (NVSEF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Novartis AG (NVSEF) Enterprise Value vs. Peers

How is NVSEF’s Enterprise Value compared to its peers?

Novartis AG’s Enterprise Value is less than Roche Holding AG (227.52B), less than AstraZeneca PLC (234.40B), less than Roche Holding AG (234.35B), greater than Sanofi (133.10B), greater than Bristol-Myers Squibb Company PFD CONV 2 (183.67B), less than Astellas Pharma Inc. (0), less than Roche Holding AG (3.37T), less than Scilex Holding Company (238.14B), greater than Novartis AG (199.99M), less than AstraZeneca PLC (222.57B), less than GSK plc (230.26B), greater than Bayer Aktiengesellschaft (52.06B), greater than Organon & Co. (14.80B), greater than Horizon Therapeutics Public Limited Company (12.68B), greater than null (210.00M),

Build a custom stock screener for Novartis AG (NVSEF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Novartis AG using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Novartis AG (NVSEF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Novartis AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.